Reduced-Intensity Hematopoietic Cell Transplantation in Older Patients With AML/MDS: Umbilical Cord Blood Is a Feasible Option for Patients Without HLA-matched Sibling Donors

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2011.114
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: Comparable Outcomes With Unrelated Umbilical Cord Blood and HLA-Identical Sibling Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2011English

Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning Without Antithymocyte Globulin in Adult Patients With Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Prognostic Value of the Hematopoietic Cell Transplantation Comorbidity Index for Patients Undergoing Reduced-Intensity Conditioning Cord Blood Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

High-Resolution HLA Matching in Double-Umbilical-Cord-Blood Reduced-Intensity Transplantation in Adults

Transfusion
AllergyImmunologyHematology
2009English

Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab From HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients With Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Bone Marrow Transplantation
TransplantationHematology
2016English

Allogeneic Blood Cell Transplantation Following Reduced-Intensity Conditioning Is Effective Therapy for Older Patients With Myelofibrosis With Myeloid Metaplasia

Blood
BiochemistryImmunologyCell BiologyHematology
2002English

Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Umbilical Cord Blood Stem Cell Transplantation From Unrelated HLA-matched Donor in an Infant With Severe Congenital Neutropenia

Bone Marrow Transplantation
TransplantationHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy